Chen Liuyuan, Su Yuangang, Wang Chaofeng, Huang Qian, Chen Weiwei, Hai Na, Wang Jikang, Lian Haoyu, Zhao Jinmin, Xu Jiake, Liu Qian
Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China.
Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, Guangxi 530021, China.
Theranostics. 2024 Nov 4;14(19):7554-7568. doi: 10.7150/thno.99565. eCollection 2024.
Osteoclasts are giant bone-resorbing cells that need vigorous mitochondrial respiration to support their activation. Rc3h1, an RNA-binding protein, precisely governs the homeostasis of mRNA. However, the precise role of Rc3h1 in regulating iron metabolism and mitochondrial respiration in osteoclasts is not yet understood. We generated Rc3h1-deficient mice in osteoclast precursors and mature osteoclasts. The bone mass and osteoclast activity in bone tissues were evaluated. Moreover, we assessed the differentiation, bone resorption, iron content, and mitochondrial function of osteoclasts . In the end, the target gene of Rc3h1 and its role in mediating the effect of Rc3h1 on mitochondrial respiration in osteoclasts were further investigated. Mice lacking Rc3h1 exhibit low bone mass. In addition, Rc3h1 deletion in osteoclasts significantly promotes osteoclast activation. Mechanistically, Rc3h1 post-transcriptionally represses the expression of transferrin receptor 1 (Tfr1), restricting iron absorption and mitochondrial respiration in osteoclasts. Inhibition of Tfr1 in Rc3h1-deficient osteoclasts diminishes excessive osteoclast formation and mitochondrial respiration. These findings suggest that Rc3h1 has a negative effect on osteoclast activation via limiting iron resorption and mitochondrial respiration. Finally, targeting the Rc3h1/Tfr1 axis might represent a potential therapeutic approach for bone-loss diseases.
破骨细胞是巨大的骨吸收细胞,需要旺盛的线粒体呼吸来支持其活化。Rc3h1是一种RNA结合蛋白,精确调控mRNA的稳态。然而,Rc3h1在调节破骨细胞铁代谢和线粒体呼吸中的精确作用尚不清楚。我们在破骨细胞前体和成熟破骨细胞中构建了Rc3h1缺陷小鼠。评估了骨组织中的骨量和破骨细胞活性。此外,我们还评估了破骨细胞的分化、骨吸收、铁含量和线粒体功能。最后,进一步研究了Rc3h1的靶基因及其在介导Rc3h1对破骨细胞线粒体呼吸作用中的作用。缺乏Rc3h1的小鼠表现出低骨量。此外,破骨细胞中Rc3h1的缺失显著促进破骨细胞活化。机制上,Rc3h1在转录后抑制转铁蛋白受体1(Tfr1)的表达,限制破骨细胞的铁吸收和线粒体呼吸。在Rc3h1缺陷的破骨细胞中抑制Tfr1可减少过度的破骨细胞形成和线粒体呼吸。这些发现表明,Rc3h1通过限制铁吸收和线粒体呼吸对破骨细胞活化具有负面影响。最后,靶向Rc3h1/Tfr1轴可能代表一种治疗骨质流失疾病的潜在方法。